208 related articles for article (PubMed ID: 28566220)
1. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer.
McSorley ST; Black DH; Horgan PG; McMillan DC
Clin Nutr; 2018 Aug; 37(4):1279-1285. PubMed ID: 28566220
[TBL] [Abstract][Full Text] [Related]
2. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
[TBL] [Abstract][Full Text] [Related]
4. The combination of body composition conditions and systemic inflammatory markers has prognostic value for patients with gastric cancer treated with adjuvant chemoradiotherapy.
Li Y; Wang WB; Yang L; Wang QY; Dai J; Xia L; Peng J; Zhou FX; Wei YC; Shi HP
Nutrition; 2022 Jan; 93():111464. PubMed ID: 34678715
[TBL] [Abstract][Full Text] [Related]
5. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
Shirdel M; Andersson F; Myte R; Axelsson J; Rutegård M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
[No Abstract] [Full Text] [Related]
6. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
[TBL] [Abstract][Full Text] [Related]
7. Host phenotype is associated with reduced survival independent of tumour biology in patients with colorectal liver metastases.
van Dijk DPJ; Krill M; Farshidfar F; Li T; Rensen SS; Olde Damink SWM; Dixon E; Sutherland FR; Ball CG; Mazurak VC; Baracos VE; Bathe OF
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):123-130. PubMed ID: 30378742
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
9. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H
Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742
[TBL] [Abstract][Full Text] [Related]
10. Normocytic anaemia is associated with systemic inflammation and poorer survival in patients with colorectal cancer treated with curative intent.
McSorley ST; Johnstone M; Steele CW; Roxburgh CSD; Horgan PG; McMillan DC; Mansouri D
Int J Colorectal Dis; 2019 Mar; 34(3):401-408. PubMed ID: 30515556
[TBL] [Abstract][Full Text] [Related]
11. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Follow-Up of Patients Undergoing Resection of TNM Stage I Colorectal Cancer: An Analysis of Tumour and Host Determinants of Outcome.
Mansouri D; Powell AG; Park JH; McMillan DC; Horgan PG
World J Surg; 2016 Jun; 40(6):1485-91. PubMed ID: 26920405
[TBL] [Abstract][Full Text] [Related]
14. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the mode of presentation, CT-derived body composition, systemic inflammatory grade and survival in colon cancer.
Golder AM; Sin LKE; Alani F; Alasadi A; Dolan R; Mansouri D; Horgan PG; McMillan DC; Roxburgh CS
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2863-2874. PubMed ID: 36218135
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer.
Leitch EF; Chakrabarti M; Crozier JE; McKee RF; Anderson JH; Horgan PG; McMillan DC
Br J Cancer; 2007 Nov; 97(9):1266-70. PubMed ID: 17923866
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer.
Dolan RD; Daly L; Sim WMJ; Fallon M; Ryan A; McMillan DC; Laird BJ
Clin Nutr; 2020 Sep; 39(9):2889-2895. PubMed ID: 31926762
[TBL] [Abstract][Full Text] [Related]
19. Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial.
Hacker UT; Hasenclever D; Baber R; Linder N; Busse H; Obermannova R; Zdrazilova-Dubska L; Valik D; Lordick F
Ann Oncol; 2022 Jul; 33(7):685-692. PubMed ID: 35395383
[TBL] [Abstract][Full Text] [Related]
20. Relationship between computed tomography-derived body composition, sex, and post-operative complications in patients with colorectal cancer.
Almasaudi AS; Dolan RD; McSorley ST; Horgan PG; Edwards C; McMillan DC
Eur J Clin Nutr; 2019 Nov; 73(11):1450-1457. PubMed ID: 30858540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
